<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1679">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05139303</url>
  </required_header>
  <id_info>
    <org_study_id>71295</org_study_id>
    <nct_id>NCT05139303</nct_id>
  </id_info>
  <brief_title>Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.</brief_title>
  <official_title>Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea. Clinical Trial and Retrospective Comparison Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isabel Moreno Hay</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess the efficacy of the Orthoapnea NOA® mandibular&#xD;
      advancement device and describe the percentage of advancement (%) needed to reach efficacy,&#xD;
      and to retrospectively compare with other MAD designs in the management of obstructive sleep&#xD;
      apnea. Additionally, to describe patient compliance and adherence to the therapy with the&#xD;
      Orthoapnea NOA® device, and to assess the incidence and prevalence of signs, symptoms, and&#xD;
      diagnosis of temporomandibular disorders (TMD) associated to the use of the Orthoapnea NOA®&#xD;
      mandibular advancement device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the efficacy of the Orthoapnea NOA® mandibular advancement device and describe the percentage of advancement (%) needed to reach efficacy.</measure>
    <time_frame>16 weeks.</time_frame>
    <description>Assessment of efficacy of the device: After delivery, the MAD will be advanced 10% every 2 weeks until maximum therapeutic benefit. Sleep parameters (AHI, RDI, min. and average oxygen saturation) will be extracted from the initial PSG, and from a final confirmatory home sleep apnea test. The efficacy will be stablished based on: Criterion I: &gt; 50% reduction of AHI/RDI; Criterion II: AHI/RDI &lt; 5 events/hour or &lt;15 events/hour with a significant reduction of OSA associates symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To retrospectively compare with other MAD designs.</measure>
    <time_frame>16 weeks.</time_frame>
    <description>Retrospective comparison with other MAD designs: Archival data will be extracted from records of patients that started MAD therapy for OSA at the same center between 01/01/2010-08/17/2021, and that had a second sleep study performed to assess the effectiveness of the MAD. Data regarding demographic characteristics (age (years), gender (male, female), BMI (kg/m²) and OSA diagnosis (mild, moderate, and severe)), sleep parameters (AHI (events/hour), RDI (events/hour), minimum and average oxygen saturation (%)), level of advancement of the MAD (%), and compliance (nights of use per week) of use will be extracted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describe patient compliance and adherence to the therapy with the Orthoapnea NOA® device.</measure>
    <time_frame>16 weeks.</time_frame>
    <description>The self-reported use of MAD will be assessed at each follow-up via questionnaire on a five-point checklist (number hours per night and nights per week). Compliance will be defined as wearing the appliance for ≥4 hours per night during at least 70% of the nights.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>To assess the incidence and prevalence of signs, symptoms, and diagnosis of temporomandibular disorders (TMD) associated to the use of the Orthoapnea NOA® mandibular advancement device.</measure>
    <time_frame>16 weeks.</time_frame>
    <description>The presence of signs, symptoms of TMD will be assessed following the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>MAD therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orthoapnea NOA®</intervention_name>
    <description>The efficacy of the appliance for the management of OSA will be stablished based on two criteria. Criterion I: &gt; 50% reduction of AHI/RDI. Criterion II: AHI/RDI &lt; 5 events/hour or &lt;15 events/hour with a significative reduction of OSA associates symptoms as defined before. Therapeutic failure will be established when at 100% of advancement of the device, there is less than 50% of reduction of the AHI/RDI with a residual AHI/RDI &gt;5 events/hour with OSA associates symptoms.</description>
    <arm_group_label>MAD therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: &gt;18 and &lt;80 years old.&#xD;
&#xD;
          -  No history of previous use of a MAD.&#xD;
&#xD;
          -  Diagnosis of OSA by a sleep physician based on a PSG or HSAT (done &gt;12 months before&#xD;
             evaluation date or &gt; 12 months with &gt;10% variation of BMI).&#xD;
&#xD;
          -  Upon clinical examination: &gt;8 teeth per arch; range of anteroposterior mandibular&#xD;
             mobility &gt;5 mm.&#xD;
&#xD;
          -  Informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with concomitant diagnosed sleep disorders (i.e. insomnia, narcolepsy,&#xD;
             restless legs syndrome, rapid eye movement sleep behavior disorder).&#xD;
&#xD;
          -  History of previous allergic reaction to the appliance material (Polyamide 12).&#xD;
&#xD;
          -  Patients using combination therapy for the management of OSA (i.e. PAP therapy or&#xD;
             positional therapy).&#xD;
&#xD;
          -  Upon clinical examination: periodontal disease (&gt;4 mm on periodontal probing, with&#xD;
             bleeding on probing, visual signs of periodontal inflammation); tooth horizontal&#xD;
             mobility &gt;1 mm, vertical mobility, and unfavorable crown to root ratio; open cavities,&#xD;
             loose or fractured restorations, or patient undergoing restorative dental treatments.&#xD;
&#xD;
          -  Exaggerated gag reflex.&#xD;
&#xD;
          -  Lack of coordination or dexterity.&#xD;
&#xD;
          -  Inadequate English comprehension.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Diego Fernandez Vial</last_name>
    <phone>8593235500</phone>
    <email>dfe@uky.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabel Moreno Hay</last_name>
    <phone>8593235500</phone>
    <email>imo226@uky.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Orofacial Pain Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel M Hay, DDS PhD</last_name>
      <phone>859-323-8873</phone>
      <phone_ext>9</phone_ext>
      <email>imo226@uky.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>Isabel Moreno Hay</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>mandibular advancement device</keyword>
  <keyword>oral appliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

